Estrone
Based on 6 publication(s) in Google Scholar
Estrone (E1) is a natural estrogenic hormone. Estrone is the main representative of the endogenous estrogens and is produced by several tissues, especially adipose tissue. Estrone is the result of the process of aromatization of androstenedione that occurs in fat cells.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.96%
- CAS. Nr.: 53-16-7
- Formel: C18H22O2
- Molecular Weight:270.37
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Estrone
More- Biosens Bioelectron. 2022 Nov 1:215:114548. [Abstract]
- Anal Chem. 2026 Jun 16;98(23):16962-16970. [Abstract]
- Environ Health (Wash). 2025 Jan 10;3(4):414-424. [Abstract]
- Cell Rep Methods. 2023 Oct 23;3(10):100599. [Abstract]
- J Cell Mol Med. 2020 Dec;24(23):13775-13788. [Abstract]
- Physiol Rep. 2024 Sep;12(17):e70047. [Abstract]
-
RT-PCR
-
IF
-
WB
-
Cell Imaging/Staining
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Human Endogenous Metabolite |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
600 nM
Compound: E1
|
Inhibition of 17beta-HSD1 expressed in HEK 293 cells assessed as conversion of [14C]estrone to [14C]estradiol
Inhibition of 17beta-HSD1 expressed in HEK 293 cells assessed as conversion of [14C]estrone to [14C]estradiol
|
[PMID: 18372081] |
| HEK293 | IC50 |
810 nM
Compound: E1
|
Inhibition of 17beta-HSD1 expressed in HEK 293 cells assessed as conversion of [14C]estrone to [14C]estradiol using NADH
Inhibition of 17beta-HSD1 expressed in HEK 293 cells assessed as conversion of [14C]estrone to [14C]estradiol using NADH
|
[PMID: 18372081] |
| HeLa | EC50 |
0.7 nM
Compound: estrone
|
Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.
Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.
|
[PMID: 11906280] |
| HeLa | EC50 |
2.1 nM
Compound: estrone
|
Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.
Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.
|
[PMID: 11906280] |
| HeLa | EC50 |
166 nM
Compound: estrone
|
Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM
Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM
|
[PMID: 16610787] |
| HeLa | EC50 |
26 nM
Compound: estrone
|
Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay
Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay
|
[PMID: 16610787] |
| K562 | IC50 |
>10 μM
Compound: Estrone
|
TP_TRANSPORTER: drug resistance(SN-38) in BCRP-expressing K562 cells
TP_TRANSPORTER: drug resistance(SN-38) in BCRP-expressing K562 cells
|
[PMID: 12533678] |
| K562 | IC50 |
3 μM
Compound: Estrone
|
TP_TRANSPORTER: drug resistance(Mitoxantrone) in BCRP-expressing K562 cells
TP_TRANSPORTER: drug resistance(Mitoxantrone) in BCRP-expressing K562 cells
|
[PMID: 12533678] |
| Sf9 | IC50 |
96 nM
Compound: 1, E1
|
Displacement of [3H]17beta-estradiol from human ERalpha expressed in SF9 cells
Displacement of [3H]17beta-estradiol from human ERalpha expressed in SF9 cells
|
[PMID: 19836949] |
| T47D | IC50 |
0.33 μM
Compound: E1
|
Inhibition of 17-beta HSD1 in T47D cells
Inhibition of 17-beta HSD1 in T47D cells
|
[PMID: 16480268] |
| T47D | IC50 |
218 nM
Compound: E1, estrone
|
Inhibition of 17beta-HSD1 in human T47D cells assessed as inhibition of transformation of [14C]-estrone into [14C]estrogen
Inhibition of 17beta-HSD1 in human T47D cells assessed as inhibition of transformation of [14C]-estrone into [14C]estrogen
|
[PMID: 18035543] |
Estrone is the main endogenous estrogen in postmenopausal women[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 53-16-7
-
Appearance Solid
-
Molecular Weight 270.37
-
Formel C18H22O2
-
Color White to off-white
-
SMILES
C[C@]1([C@](CC2)([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC1)C2=O
-
Synonyms
E1; Oestrone
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Biosens Bioelectron
Split aptamer regulated CRISPR/Cas12a biosensor for 17β-estradiol through a gap-enhanced Raman tags based lateral flow strategy. [Abstract]2022 Nov 1:215:114548. PMID: 35870335 -
Anal Chem
High-Throughput Reactive Desorption Electrospray Ionization Mass Spectrometry for Targeted Derivatization and Analysis of Poorly Ionized Small Molecules. [Abstract]2026 Jun 16;98(23):16962-16970. PMID: 42223360 -
Environ Health (Wash)
Fish Skin Mucus Vitellogenin as a Noninvasive, Sensitive Biomarker for Aquatic Xenoestrogens. [Abstract]2025 Jan 10;3(4):414-424. PMID: 40270534 -
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
J Cell Mol Med
CXADR-like membrane protein protects against heart injury by preventing excessive pyroptosis after myocardial infarction. [Abstract]2020 Dec;24(23):13775-13788. PMID: 33084169
Estrone purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2020 Dec;24(23):13775-13788. [Abstract]
The mRNA and protein levels of CLMP from male primary fibroblasts in the estrogen (Estrone (300 pg/mL; 48 h)) treatment and normal group.
Estrone purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2020 Dec;24(23):13775-13788. [Abstract]
The mRNA and protein levels of CLMP from female primary fibroblasts in the estrogen ((Estrone (300 pg/mL; 48 h)) ) treatment and normal group.
-
Physiol Rep
Estrogen-dependent gene regulation: Molecular basis of TIMP-1 as a sex-specific biomarker for acute lung injury. [Abstract]2024 Sep;12(17):e70047. PMID: 39267201
Estrone purchased from MedChemExpress. Usage Cited in: Physiol Rep. 2024 Sep;12(17):e70047. [Abstract]
IMR-90 and MLg cells were treated with 100 nM E1 (Estrone) or E2 for 6 h. TIMP-1 mRNA expression was measured using qPCR. The results showed that both E1 (Estrone) and E2 could induce TIMP-1 expression in IMR-90 cells at the mRNA level.
Estrone purchased from MedChemExpress. Usage Cited in: Physiol Rep. 2024 Sep;12(17):e70047. [Abstract]
MLg cells were treated with or without 100 nM E1 (Estrone) for 24 h as indicated. MLg cells were immunostained for TIMP-1 (green). The nuclei were stained with DAPI. The results showed that TIMP-1 protein was induced in MLg fibroblasts 24 h after treatment with E1 (Estrone). Scale bar = 100 μm. ns, p > 0.05.
Lösungsmittel & Löslichkeit
DMSO : 25 mg/mL (92.47 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : < 0.1 mg/mL (insoluble)
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.5 mg/mL (9.25 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (275 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Portuguese - PT (419 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Caupos E, et al. Photodegradation of estrone enhanced by dissolved organic matter under simulated sunlight. Water Res. 2011;45(11):3341-3350. [Content Brief]
[2]. de Padua Mansur A, et al. Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease. ScientificWorldJournal. 2012;2012:363595. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.6986 mL | 18.4932 mL | 36.9864 mL | 92.4659 mL |
| 5 mM | 0.7397 mL | 3.6986 mL | 7.3973 mL | 18.4932 mL | |
| 10 mM | 0.3699 mL | 1.8493 mL | 3.6986 mL | 9.2466 mL | |
| 15 mM | 0.2466 mL | 1.2329 mL | 2.4658 mL | 6.1644 mL | |
| 20 mM | 0.1849 mL | 0.9247 mL | 1.8493 mL | 4.6233 mL | |
| 25 mM | 0.1479 mL | 0.7397 mL | 1.4795 mL | 3.6986 mL | |
| 30 mM | 0.1233 mL | 0.6164 mL | 1.2329 mL | 3.0822 mL | |
| 40 mM | 0.0925 mL | 0.4623 mL | 0.9247 mL | 2.3116 mL | |
| 50 mM | 0.0740 mL | 0.3699 mL | 0.7397 mL | 1.8493 mL | |
| 60 mM | 0.0616 mL | 0.3082 mL | 0.6164 mL | 1.5411 mL | |
| 80 mM | 0.0462 mL | 0.2312 mL | 0.4623 mL | 1.1558 mL |